首页> 外文OA文献 >Successful Combined Treatment with Maximal Androgen Blockade (MAB), Intra Arterial Chemotherapy and Radiation for Advanced Prostatic Ductal Adenocarcinoma : Report of Two Cases
【2h】

Successful Combined Treatment with Maximal Androgen Blockade (MAB), Intra Arterial Chemotherapy and Radiation for Advanced Prostatic Ductal Adenocarcinoma : Report of Two Cases

机译:成功结合最大雄激素阻断(MAB),动脉内化学疗法和放射治疗治疗晚期前列腺导管腺癌:两例报告

摘要

The first case was in a 73-year-old man with macrohematuria. The second case was in a 59-year-old man with pollakiuria. Their serum prostate specific antigen levels were slightly elevated and urinary cytology was negative. Histological examination by prostatic needle biopsy and biopsy from bladder neck showed prostatic ductal adenocarcinoma. Clinical stage on computed tomography and magnetic resonance imaging was T4N0M0 in both cases. After 10-month maximal androgen blockade(MAB) and arterial cemotherapy using reservoir system, radiation therapy was performed. After that, low dose FP-chemotherapy (5-fluorouracil 600 mg/day,cisplatinum 10 mg/day) was performed for 28 days in the first case. At present, there are no signs of recurrence or metastasis in either case.
机译:第一例是一名73岁的男子,患有大血尿。第二例是一名59岁男子患有尿频尿症。他们的血清前列腺特异性抗原水平轻微升高,尿细胞学检查为阴性。前列腺穿刺活检和膀胱颈活检的组织学检查显示为前列腺导管腺癌。在这两种情况下,计算机断层扫描和磁共振成像的临床阶段均为T4N0M0。经过10个月的最大雄激素阻滞(MAB)和使用储库系统的动脉瘤治疗后,进行了放射治疗。此后,在第一种情况下,进行了低剂量FP化疗(5-氟尿嘧啶600 mg /天,顺铂10 mg /天),持续28天。目前,在任何情况下都没有复发或转移的迹象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号